BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 14603451)

  • 1. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer.
    Epstein JB; Feldman R; Dolor RJ; Porter SR
    Head Neck; 2003 Nov; 25(11):911-21. PubMed ID: 14603451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
    Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
    Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions.
    Güneri P; Epstein JB; Kaya A; Veral A; Kazandı A; Boyacioglu H
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):155-61. PubMed ID: 21112183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical evaluation of Oratest in detecting oral mucosal lesions].
    Cheng B; Yang L
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):124-6. PubMed ID: 12838698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions.
    Ram S; Siar CH
    Int J Oral Maxillofac Surg; 2005 Jul; 34(5):521-7. PubMed ID: 16053872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
    Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients.
    Fischer DJ; Epstein JB; Morton TH; Schwartz SM
    Oral Oncol; 2005 May; 41(5):489-96. PubMed ID: 15878753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of iodine staining for diagnosis of carcinoma in situ in the floor of mouth, and decision of adequate surgical margin.
    Watanabe A; Taniguchi M; Tsujie H; Hosokawa M; Fujita M; Sasaki S
    Auris Nasus Larynx; 2012 Apr; 39(2):193-7. PubMed ID: 21885222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of esophageal cancer synchronous with upper aerodigestive tract cancers (100 cases): value of vital staining with lugol and toluidine blue].
    Papazian A; Descombes P; Capron JP; Lorriaux A
    Gastroenterol Clin Biol; 1985 Jan; 9(1):16-22. PubMed ID: 3979722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
    Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
    J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment.
    Awan Kh; Yang Y; Morgan P; Warnakulasuriya S
    Oral Dis; 2012 Nov; 18(8):728-33. PubMed ID: 22524200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.
    Chainani-Wu N; Madden E; Cox D; Sroussi H; Epstein J; Silverman S
    Oral Dis; 2015 Oct; 21(7):879-85. PubMed ID: 26173924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening of cancerous and precancerous lesions of the oral mucosa in an at-risk population].
    Vacher C; Legens M; Rueff B; Lezy JP
    Rev Stomatol Chir Maxillofac; 1999 Oct; 100(4):180-3. PubMed ID: 10599125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolonium (toluidine blue) rinse--a screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV.
    Mashberg A
    JAMA; 1981 Jun; 245(23):2408-10. PubMed ID: 6164804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the diagnosis of oral premalignant and malignant lesions.
    Epstein JB; Zhang L; Rosin M
    J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal cytology in the follow-up of patients with treated upper aerodigestive tract malignancies.
    Leoni-Parvex S; Mihaescu A; Pellanda A; Monnier P; Bosman FT
    Cancer; 2000 Feb; 90(1):10-6. PubMed ID: 10692211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
    Epstein JB; Sciubba J; Silverman S; Sroussi HY
    Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autofluorescence and early detection of mucosal lesions in patients at risk for oral cancer.
    Moro A; Di Nardo F; Boniello R; Marianetti TM; Cervelli D; Gasparini G; Pelo S
    J Craniofac Surg; 2010 Nov; 21(6):1899-903. PubMed ID: 21119451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of oral soft-tissue lesions: the use of biopsy, toluidine blue staining, and brush biopsy.
    Handlers JP
    J Calif Dent Assoc; 2001 Aug; 29(8):602-6. PubMed ID: 11577671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
    Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.